Xiaoling Tong

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 5

Top Topics

Ejection Fraction

Epidermal Growth Factor Receptor

Mitochondrial Dna

Advanced Non Small Cell Lung Cancer

Top Venues

Molecular oncology

Cancer medicine

Nature communications

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Si-Yang Liu, Hua Bao, Qun Wang, Wei-Min Mao, Yuchen Han, Xiaoling Tong, Song-Tao Xu, Lin Wu, Yu-Cheng Wei, Yong-Yu Liu, Chun Chen, Ying Cheng, Rong Yin, Fan Yang, Sheng-Xiang Ren, Xiao-Fei Li, Jian Li, Cheng Huang, Zhi-Dong Liu, Shun Xu, Ke-Neng Chen, Shi-Dong Xu, Lun-Xu Liu, Ping Yu, Bu-Hai Wang, Hai-Tao Ma, Hong-Hong Yan, Song Dong, Xu Chao Zhang, Jian Su, Jin-Ji Yang, Xue-Ning Yang, Qing Zhou, Xue Wu, Yang W Shao, Wen-Zhao Zhong, Yi-Long Wu
Genomic signatures define three subtypes of EGFR-mutant stage II-III non-small-cell lung cancer with distinct adjuvant therapy outcomes. Nature communications 12 (1) (2021)
Lei Cai, Yong Chen, Xiaoling Tong, Xue Wu, Hua Bao, Yang Shao, Zhuang Luo, Xuming Wang, Yang Cao
The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients. International journal of cancer (2021)
Meiying Cui, Yuchen Han, Pan Li, Jianying Zhang, Qiuxiang Ou, Xiaoling Tong, Ruiying Zhao, Nan Dong, Xue Wu, Wencai Li, Guozhong Jiang
Molecular and clinicopathological characteristics of ROS1-rearranged non-small-cell lung cancers identified by next-generation sequencing. Molecular oncology 14 (11) (2020)
YanRu Qin, Hong Jian, Xiaoling Tong, Xue Wu, Fufeng Wang, Yang W Shao, Xinmin Zhao
Variability of EGFR exon 20 insertions in 24 468 Chinese lung cancer patients and their divergent responses to EGFR inhibitors. Molecular oncology 14 (8) (2020)
Honghai Dai, Yang W Shao, Xiaoling Tong, Xue Wu, Jiaohui Pang, Alei Feng, Zhe Yang
YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma. Cancer medicine 9 (5) (2019)